Cargando…
Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer
SIMPLE SUMMARY: Breast cancer is the most common cancer in women, affecting 1 in 20 women globally. Breast cancer is divided into four subtypes: luminal A, luminal B, HER2-enriched, and basal-like. Estrogen receptor-positive breast cancer accounts for nearly 80% of all breast cancer cases and most b...
Autores principales: | Waddell, Aaron, Mahmud, Iqbal, Ding, Haocheng, Huo, Zhiguang, Liao, Daiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200112/ https://www.ncbi.nlm.nih.gov/pubmed/34199844 http://dx.doi.org/10.3390/cancers13112799 |
Ejemplares similares
-
Protein Lysine Acetylation
by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015) -
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers
por: Waddell, Aaron R., et al.
Publicado: (2021) -
Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016) -
Epigenetic mechanisms to propagate histone acetylation by p300/CBP
por: Kikuchi, Masaki, et al.
Publicado: (2023) -
Is histone acetylation the most important physiological function for CBP and p300?
por: Bedford, David C., et al.
Publicado: (2012)